2-Fluorglukose (18-F) Rotop Pharmaka

2-Fluorglukose (18-F) Rotop Pharmaka is a radiopharmaceutical used in PET imaging for metabolic activity assessment. It is a glucose analog labeled with fluorine-18, commonly employed in oncology and neurology. This product is intended for intravenous administration under professional supervision.

Fludeoxyglucose (18F) is primarily used in positron emission tomography (PET) scans to evaluate metabolic activity in tissues. It helps in identifying cancerous cells, monitoring treatment response, and assessing neurological conditions. The radiotracer is widely used in oncology for tumor detection and staging. It is also utilized in cardiology and neurology for assessing brain function and cardiac viability.

After intravenous injection, Fludeoxyglucose (18F) distributes throughout the body, accumulating in tissues with high metabolic activity such as the brain, heart, and certain tumors. The radiotracer emits positrons, which are detected by the PET scanner to create detailed images. Patients may experience mild discomfort at the injection site, and the effects are typically observed within minutes to hours.

Fludeoxyglucose (18F) should only be handled and administered by trained healthcare professionals. Patients should avoid strenuous activity before the scan and fast for several hours prior to the procedure. Pregnant or breastfeeding individuals should inform their healthcare provider due to potential risks. The radiopharmaceutical must be stored and disposed of according to regulatory guidelines for radioactive materials.

No significant drug interactions are reported with Fludeoxyglucose (18F) itself, as it is a radiotracer rather than a therapeutic agent. However, medications that affect glucose metabolism, such as insulin or oral hypoglycemics, may influence imaging results. Patients should disclose all medications and medical conditions to their healthcare provider before the scan. Alcohol and caffeine consumption should be avoided prior to the procedure to ensure accurate results.